Results

Total Results: 7,248 records

Showing results for "infant".

  1. meps.ahrq.gov/data_stats/MEPSnet/mepsnet06doc.shtml
    December 31, 2006 - This edit was applied because discharges for infants without complications after birth were not
  2. meps.ahrq.gov/data_stats/MEPSnet/mepsnet10doc.shtml
    December 31, 2010 - This edit was applied because discharges for infants without complications after birth were not
  3. meps.ahrq.gov/data_stats/MEPSnet/mepsnet11doc.shtml
    December 31, 2011 - This edit was applied because discharges for infants without complications after birth were not
  4. meps.ahrq.gov/data_stats/MEPSnet/mepsnet09doc.shtml
    December 31, 2009 - This edit was applied because discharges for infants without complications after birth were not
  5. meps.ahrq.gov/data_stats/MEPSnet/mepsnet12doc.shtml
    December 31, 2012 - This edit was applied because discharges for infants without complications after birth were not
  6. nhqrnet.ahrq.gov/inhqrdr/xls/DATABASES_WITHOUT_MEASURES.xlsx
    June 01, 2013 - NHSN, these locations are further characterized according to patient population: adults, children, or infants
  7. nhqrnet.ahrq.gov/inhqrdr/static/xls/DATABASES_WITHOUT_MEASURES.xlsx
    June 01, 2013 - NHSN, these locations are further characterized according to patient population: adults, children, or infants
  8. www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-238-fullreport.pdf
    October 01, 2019 - Population – infants (29 days to 1 year) (specify age range): Yes; all ages in this range. q.
  9. www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-238-fullreport.pdf
    October 01, 2019 - Population – infants (29 days to 1 year) (specify age range): Yes; all ages in this range. q.
  10. www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-238-fullreport.pdf
    October 01, 2019 - Population – infants (29 days to 1 year) (specify age range): Yes; all ages in this range. q.
  11. www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-238-fullreport.pdf
    October 01, 2019 - Population – infants (29 days to 1 year) (specify age range): Yes; all ages in this range. q.
  12. www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-238-fullreport.pdf
    October 01, 2019 - Population – infants (29 days to 1 year) (specify age range): Yes; all ages in this range. q.
  13. www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-245-fullreport.pdf
    December 01, 2019 - Population – infants (29 days to 1 year) (specify age range): No. q.
  14. www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-212-fullreport.pdf
    September 01, 2018 - Population – infants (29 days to 1 year) (specify age range): No. q.
  15. www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-244-fullreport.pdf
    December 01, 2019 - Population – infants (29 days to 1 year) (specify age range): No. q.
  16. www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-245-fullreport.pdf
    December 01, 2019 - Population – infants (29 days to 1 year) (specify age range): No. q.
  17. www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-244-fullreport.pdf
    December 01, 2019 - Population – infants (29 days to 1 year) (specify age range): No. q.
  18. www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-212-fullreport.pdf
    September 01, 2018 - Population – infants (29 days to 1 year) (specify age range): No. q.
  19. www.cahps.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-244-fullreport.pdf
    December 01, 2019 - Population – infants (29 days to 1 year) (specify age range): No. q.
  20. www.cahps.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-212-fullreport.pdf
    September 01, 2018 - Population – infants (29 days to 1 year) (specify age range): No. q.